Search Results - "Meshel, Tsipi"

Refine Results
  1. 1

    Tumor-Stroma-Inflammation Networks Promote Pro-metastatic Chemokines and Aggressiveness Characteristics in Triple-Negative Breast Cancer by Liubomirski, Yulia, Lerrer, Shalom, Meshel, Tsipi, Rubinstein-Achiasaf, Linor, Morein, Dina, Wiemann, Stefan, Körner, Cindy, Ben-Baruch, Adit

    Published in Frontiers in immunology (12-04-2019)
    “…The tumor microenvironment (TME) plays key roles in promoting disease progression in the aggressive triple-negative subtype of breast cancer (TNBC;…”
    Get full text
    Journal Article
  2. 2

    Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition by Soria, Gali, Ofri-Shahak, Maya, Haas, Ilana, Yaal-Hahoshen, Neora, Leider-Trejo, Leonor, Leibovich-Rivkin, Tal, Weitzenfeld, Polina, Meshel, Tsipi, Shabtai, Esther, Gutman, Mordechai, Ben-Baruch, Adit

    Published in BMC cancer (12-04-2011)
    “…The inflammatory chemokines CCL2 (MCP-1) & CCL5 (RANTES) and the inflammatory cytokines TNFα & IL-1β were shown to contribute to breast cancer development and…”
    Get full text
    Journal Article
  3. 3

    Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer by Liubomirski, Yulia, Lerrer, Shalom, Meshel, Tsipi, Morein, Dina, Rubinstein-Achiasaf, Linor, Sprinzak, David, Wiemann, Stefan, Körner, Cindy, Ehrlich, Marcelo, Ben-Baruch, Adit

    Published in Frontiers in immunology (24-04-2019)
    “…Stromal cells and pro-inflammatory cytokines play key roles in promoting the aggressiveness of triple-negative breast cancers (TNBC; Basal/Basal-like). In our…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The Beta Subunit of Hemoglobin (HBB2/HBB) Suppresses Neuroblastoma Growth and Metastasis by Maman, Shelly, Sagi-Assif, Orit, Yuan, Weirong, Ginat, Ravit, Meshel, Tsipi, Zubrilov, Inna, Keisari, Yona, Lu, Weiyue, Lu, Wuyuan, Witz, Isaac P

    Published in Cancer research (Chicago, Ill.) (01-01-2017)
    “…Soluble pulmonary factors have been reported to be capable of inhibiting the viability of cancer cells that metastasize to the lung, but the molecular identity…”
    Get full text
    Journal Article
  6. 6

    Inflammatory Factors of the Tumor Microenvironment Induce Plasticity in Nontransformed Breast Epithelial Cells: EMT, Invasion, and Collapse of Normally Organized Breast Textures by Leibovich-Rivkin, Tal, Liubomirski, Yulia, Bernstein, Biana, Meshel, Tsipi, Ben-Baruch, Adit

    Published in Neoplasia (New York, N.Y.) (01-12-2013)
    “…Abstract Nontransformed breast epithelial cells that are adjacent to tumor cells are constantly exposed to tumor necrosis factor-α (TNFα) and interleukin-1β…”
    Get full text
    Journal Article
  7. 7

    Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7‐driven metastatic spread of luminal‐A breast tumors by Weitzenfeld, Polina, Kossover, Olga, Körner, Cindy, Meshel, Tsipi, Wiemann, Stefan, Seliktar, Dror, Legler, Daniel F., Ben‐Baruch, Adit

    Published in Journal of leukocyte biology (01-06-2016)
    “…Luminal‐A‐specific regulation of the CCR7‐CCL21 axis in cancer LN metastasis Chemokine axes have been shown to mediate site‐specific metastasis in breast…”
    Get full text
    Journal Article
  8. 8

    CXCL10 promotes invasion-related properties in human colorectal carcinoma cells by ZIPIN-ROITMAN, Adi, MESHEL, Tsipi, SAGI-ASSIF, Orit, SHALMON, Bruria, AVIVI, Camila, PFEFFER, Raphael M, WITZ, Isaac P, BEN-BARUCH, Adit

    Published in Cancer research (Chicago, Ill.) (01-04-2007)
    “…CXCL10 was recently shown to exert antimalignancy functions by influencing the tumor microenvironment. Here, we have taken a different approach, investigating…”
    Get full text
    Journal Article
  9. 9

    The Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Breast Cancer Are Regulated by N-Linked Glycosylation-Dependent Activation of STAT3 and STAT1 by Erlichman, Nofar, Meshel, Tsipi, Baram, Tamir, Abu Raiya, Alaa, Horvitz, Tamar, Ben-Yaakov, Hagar, Ben-Baruch, Adit

    Published in Cells (Basel, Switzerland) (23-09-2023)
    “…PD-L1 has been characterized as an inhibitory immune checkpoint, leading to the suppression of potential anti-tumor immune activities in many cancer types. In…”
    Get full text
    Journal Article
  10. 10
  11. 11

    The metastatic microenvironment: Brain-residing melanoma metastasis and dormant micrometastasis by Izraely, Sivan, Sagi-Assif, Orit, Klein, Anat, Meshel, Tsipi, Tsarfaty, Galia, Pasmanik-Chor, Metsada, Nahmias, Clara, Couraud, Pierre-Olivier, Ateh, Eugene, Bryant, Joseph L., Hoon, Dave S.B., Witz, Isaac P.

    Published in International journal of cancer (01-09-2012)
    “…Brain metastasis occurs frequently in melanoma patients with advanced disease whereby the prognosis is dismal. The underlying mechanisms of melanoma brain…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Co-Inflammatory Roles of TGFβ1 in the Presence of TNFα Drive a Pro-inflammatory Fate in Mesenchymal Stem Cells by Lerrer, Shalom, Liubomirski, Yulia, Bott, Alexander, Abnaof, Khalid, Oren, Nino, Yousaf, Afsheen, Körner, Cindy, Meshel, Tsipi, Wiemann, Stefan, Ben-Baruch, Adit

    Published in Frontiers in immunology (11-05-2017)
    “…High plasticity is a hallmark of mesenchymal stem cells (MSCs), and as such, their differentiation and activities may be shaped by factors of their…”
    Get full text
    Journal Article
  14. 14

    Breast Cancer: Coordinated Regulation of CCL2 Secretion by Intracellular Glycosaminoglycans and Chemokine Motifs by Lebel-Haziv, Yaeli, Meshel, Tsipi, Soria, Gali, Yeheskel, Adva, Mamon, Elad, Ben-Baruch, Adit

    Published in Neoplasia (New York, N.Y.) (01-09-2014)
    “…Abstract The chemokine CCL2 (MCP-1) has been identified as a prominent tumor-promoting factor in breast cancer. The major source for CCL2 is in the tumor…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Continuous Inflammatory Stimulation Leads via Metabolic Plasticity to a Prometastatic Phenotype in Triple-Negative Breast Cancer Cells by Morein, Dina, Rubinstein-Achiasaf, Linor, Brayer, Hadar, Dorot, Orly, Pichinuk, Edward, Ben-Yaakov, Hagar, Meshel, Tsipi, Pasmanik-Chor, Metsada, Ben-Baruch, Adit

    Published in Cells (Basel, Switzerland) (31-05-2021)
    “…Chronic inflammation promotes cancer progression by affecting the tumor cells and their microenvironment. Here, we demonstrate that a continuous stimulation…”
    Get full text
    Journal Article
  17. 17
  18. 18

    A Possible Role for CXCR4 and Its Ligand, the CXC Chemokine Stromal Cell-Derived Factor-1, in the Development of Bone Marrow Metastases in Neuroblastoma by Geminder, Hila, Sagi-Assif, Orit, Goldberg, Lilach, Meshel, Tsipi, Rechavi, Gideon, Witz, Isaac P, Ben-Baruch, Adit

    Published in The Journal of immunology (1950) (15-10-2001)
    “…The homing of hemopoietic stem cells to the bone marrow is mediated by specific interactions occurring between CXCR4, which is expressed on hemopoietic stem…”
    Get full text
    Journal Article
  19. 19

    Epidermal Growth Factor and Estrogen Act by Independent Pathways to Additively Promote the Release of the Angiogenic Chemokine CXCL8 by Breast Tumor Cells by Haim, Karin, Weitzenfeld, Polina, Meshel, Tsipi, Ben-Baruch, Adit

    Published in Neoplasia (New York, N.Y.) (01-03-2011)
    “…The tumor microenvironment contains multiple cancer-supporting factors, whose joint activities promote malignancy. Here, we show that epidermal growth factor…”
    Get full text
    Journal Article
  20. 20

    Chemotherapy Shifts the Balance in Favor of CD8+ TNFR2+ TILs in Triple-Negative Breast Tumors by Baram, Tamir, Erlichman, Nofar, Dadiani, Maya, Balint-Lahat, Nora, Pavlovski, Anya, Meshel, Tsipi, Morzaev-Sulzbach, Dana, Gal-Yam, Einav Nili, Barshack, Iris, Ben-Baruch, Adit

    Published in Cells (Basel, Switzerland) (08-06-2021)
    “…Triple-negative breast cancer (TNBC) is primarily treated via chemotherapy; in parallel, efforts are made to introduce immunotherapies into TNBC treatment…”
    Get full text
    Journal Article